Lowenco develops, manufactures, markets, and installs large scale modular and highly energy efficient ultra-low temperature (“ULT”) storage solutions for commercial biopharma primarily targeting the drug substance market.
Our portfolio companies and potential investments operate in the healthcare sector, primarily based in the Nordic region. The companies we invest in shall contribute to an improved quality of care, increased availability of care, reduced or postponed need for care, more care for an existing budget and/or preventive care. We find common ground in our long-term efforts to give people the opportunity to enjoy healthier lives in the future.
Read our Annual review for 2021 here. (Opens a new tab).
Impilo creates value in its investee companies through active involvement and long-term perspective, which enable us to set positive and challenging objectives, diligently follow up on execution, provide new resources while showing an understanding and respect for the investee companies’ cultures – all in order to promote their development. Below you can read more about our investments and how our view of transparent companionship leads to robust business in the long term.
We strongly believe that true progress comes from strong partnerships. The Impilo team strives to be a talented partner with an ambitious, long-term and open approach, seeking to be the wind under the wings of others.